//Aspect Ratios for the Images

Investing in India’s Best
Product Startups

LEARN MORE
SigTuple
Eyestem
Mylo
AquaExchange
Kissht
Scrut Automation
Sugar.Fit
Darwinbox
Qapita
Zluri
AquaExchange
AquaExchange
VIEW
READ

Integrated full stack platform for inland aquaculture

Darwinbox
Darwinbox
VIEW
READ

Cloud-native, mobile-first HRMS solution for the entire employee life cycle – Hire to Retire.

Eyestem
Eyestem
VIEW
READ

Stem cell therapy platform for previously incurable diseases.

Kissht

Personal loans and loans against property (LAP) to retail customers and micro businesses, through a fully digital and fast disbursement process.

Mylo

Community led health & wellness platform catering to mother and baby care.

Qapita

Equity management platform for private markets - Captable / ESOP management and private market liquidity.

Scrut Automation
Scrut Automation
VIEW
READ

Risk-focused GRC automation platform that helps simplify and streamline compliance/information security for cloud-native companies.

SigTuple
SigTuple
VIEW
READ

Full stack platform for AI-led digital microscopy.

Sugar.Fit
Sugar.Fit
VIEW
READ

A digital health platform preventing, managing & reversing type 2 diabetes & pre-diabetes with data-driven, consumer-centric care

Zluri

Identity governance and SaaS management platform for enterprises.

Our Investment Focus

We invest in market creating business models and driven entrepreneurs to build lasting companies.

feature icon

Launchpad for Early Stage Startups

We endeavour to be a launchpad for early-stage product companies focussed on enterprise, industrial tech, healthcare & life sciences.

feature icon

Strong Fundamentals

We believe in businesses built on strong fundamentals & clear competitive advantage, and in growth that is profitable & sustainable.

feature icon

Large and Growing Markets

We look for large and growing markets, well defined problems, disruptive solutions, deep customer relationships and strong teams.

feature icon

Building for Scale

We seek to partner with entrepreneurs passionate about building in India, for the Globe.

Endiya at a glance

We walk in early when the risk is highest and write the first cheque.

SEED ROUND,

MULTIPLE ROUNDS

FIRST CHEQUE UPTO

$2Mn

We are Thematic Investors
Arrow

Our thematic approach to investing combined with our collective experience inbuilding and scaling companies enables us to catch long-term, market-creating trends ahead of others.

LEARN MORE

ALMOST ALL
COMPANIES RAISE

FOLLOW-ON FUNDING

25x

CAPITAL RAISED BY PORTFOLIO

We are Operator VCs
Arrow

We bring deep domain expertise, vast entrepreneurial experience, and a global rolodex to help realize our portfolio’s growth potential.

LEARN MORE
feature icon
Enterprise

Deep bets in digital enterprise and infosec technology.

Digital industry
Industrial Tech & Intelligent Mobility

Early investor in industrial robotics, fabless semiconductors, edge AI, electric mobility, and autonomous driving.

Digital health
Healthcare & Lifesciences

Investments across AI diagnosis, chronic disease management and cell therapy.

feature icon
Fintech

Category creating plays in digital lending, alternate investments & equity management for private markets.

In the News

SEE ALL
Lifesciences
SEE ALL
SEE ALL

How a 14-member biotech spent just $10M on a product global pharma wants to lap up

One of the three companies globally to show cell therapy results for dry AMD, an eye disorder affecting nearly 200 million globally, Bengaluru’s Eyestem is also eyeing a disruptive price.

How a 14-member biotech spent just $10M on a product global pharma wants to lap up
Lifesciences
SEE ALL
SEE ALL

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

Eyecyte-RPE trial involved 9 patients with geographic atrophy, using three ascending dose levels of hiPSC-derived RPE cells. No serious adverse events were reported, and patients showed an average vision improvement of 14.9 letters on ETDRS tests.

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy
Deep Tech
SEE ALL
SEE ALL

Robots reimagined: Perceptyne making steely strides

Will robots take over the world? Well, while that is an age-old sci-fi cliffhanger, Perceptyne’s robots aren’t plotting domination — they’re rolling up their sleeves and getting to work.

Robots reimagined: Perceptyne making steely strides

Frequently Asked Questions

01
Endiya’s Focus
faq-accordion

We are an early-stage venture capital fund that invests in globally relevant product startups. Endiya’s portfolio consists of market-creating innovations and category-defining companies. We strive to partner with exceptional entrepreneurs with the talent to build world-class companies. Sectors that we focus on are:

Arrow

Enterprise: AI, Data & Cyber Security

Arrow

Industrial Tech & Intelligent Mobility: Edge AI, Robotics, Fabless Semiconductors, Intelligent Mobility

Arrow

Healthcare: Digital Health, Biotech, Medical Devices, and Lifesciences

Arrow

Fintech: Digital Lending, Alternate Investments

02
Investment Approach
faq-accordion
Arrow

We primarily invest in seed & pre-series A rounds, with some room for flexibility on both ends.

Arrow

With a focused investment approach and additional capital reserved for the follow-on rounds, we are committed to helping founders propel growth.

Arrow

We contribute money, time, network, and resources to help you build. Given our focus and dedication, we like to have meaningful ownership.

03
Best Way to Connect with the Team
faq-accordion

The best way to approach us is through quality referrals (e.g. existing Portfolio Cos, Other entrepreneurs, Investors, Endiya Alums, Friends and Family etc).

04
Investment Process
faq-accordion

Having been entrepreneurs ourselves, we understand the gravity of swift decision making so that founders can focus on building their companies. While the duration of the investment process may vary, we typically try and decide within a month. At any time during the process, if we decide to pass on the opportunity, we communicate promptly. Broadly, this is what our investment process entails:

Arrow

Review materials / pitch deck received from founders to assess preliminary fit with our investment focus.

Arrow

Initial meetings: The Investment lead from Endiya conducts an introductory call to learn more about the idea, team and the opportunity. Subsequently, the investment lead spends more time to build their thesis and rationale and based on the interest takes the proposal to the partnership and team.

Arrow

Endiya Team Meeting: In the next step, the founders are introduced to the Endiya leadership team for a conversation. Basis continued interest, we conduct our diligence calls.

Arrow

IC Meeting: After the meeting with Endiya leadership, if all goes well, we present the investment proposal to our Investment Committee and revert with final feedback.

Know how we Work and Think

READ